Howthorn Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Profit Growth 26.64%
- Ebitda 25.00%
- Net Worth -9.44%
- Total Assets -0.36%
About Howthorn Biotech
Howthorn Biotech Private Limited (HBPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2009 and has a history of 15 years and one month. Its registered office is in Hisar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Hisar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232HR2009PTC039871
-
Company No.
039871
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Dec 2009
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Howthorn Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishan Lal
|
Director | 07-Mar-2014 | Current |
|
Puneet Maini
|
Director | 23-Dec-2009 | Current |
|
Vineet Maini
|
Director | 23-Dec-2009 | Current |
Financial Performance of Howthorn Biotech.
Howthorn Biotech Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 26.64% increase in profit. The company's net worth dipped by a decrease of 9.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Howthorn Biotech?
In 2018, Howthorn Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Martin & Brown Bio-Sciences Private LimitedPuneet Maini and Vineet Maini are mutual person
-
Vetpure Wellness Healthcare Private Limited
Puneet Maini and Vineet Maini are mutual person
-
Nicolle & Morse Technologies Private Limited
Puneet Maini is a mutual person
-
Rp Pharmaverve Private Limited
Puneet Maini is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Howthorn Biotech?
Unlock and access historical data on people associated with Howthorn Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Howthorn Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Howthorn Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
